Literature DB >> 22542491

Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation.

Louise Barbier1, Szun Szun Tay, Claire McGuffog, James A Triccas, Geoffrey W McCaughan, David G Bowen, Patrick Bertolino.   

Abstract

BACKGROUND & AIMS: Lymph nodes (LNs) play a critical role in host defence against pathogens. In rodents, lymphatic anatomy and drainage have been characterized for many different organs. Surprisingly, the LNs draining the mouse liver have not been clearly identified. This knowledge is of central importance to allow accurate characterization of immune responses to pathogens infecting the liver. It is also important for exploring immune responses in hepatic tumour models, and mechanisms underlying the relative tolerogenic properties of the liver. In this study, we used both anatomical and immunological approaches to identify the LN(s) draining the mouse liver.
METHODS: Evans Blue and purified dendritic cells were directly injected into the hepatic parenchyma.
RESULTS: Using Evans Blue, we identified three LNs adjacent to the liver that stained with the dye within the first 5 min, which we termed portal, coeliac, and first mesenteric LNs. We also provide evidence that dendritic cells (DCs) injected under the liver capsule preferentially migrate to the coeliac and portal nodes, leading to local activation of antigen-specific naïve CD8 and CD4 T cells, suggesting this is a route of lymphatic drainage from the liver. Consistent with this result, cell-associated antigen injected under the liver capsule was also cross-presented to CD8 T cells in these nodes.
CONCLUSIONS: These results suggest for the first time that the coeliac and portal nodes are the main LNs draining the liver, and that DCs exiting the liver can elicit primary T cell activation within these lymph nodes; first mesenteric nodes play a secondary role. We propose this nomenclature to be used as common designations for the observed structures.
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22542491     DOI: 10.1016/j.jhep.2012.03.023

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  27 in total

1.  CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response.

Authors:  Nicholas F Kuhn; Terence J Purdon; Dayenne G van Leeuwen; Andrea V Lopez; Kevin J Curran; Anthony F Daniyan; Renier J Brentjens
Journal:  Cancer Cell       Date:  2019-03-18       Impact factor: 31.743

2.  Type 1 interferon-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitis.

Authors:  Lifei Hou; Zuliang Jie; Yuejin Liang; Mayura Desai; Lynn Soong; Jiaren Sun
Journal:  Cell Mol Immunol       Date:  2014-07-14       Impact factor: 11.530

3.  Retinoic Acid Regulates Immune Responses by Promoting IL-22 and Modulating S100 Proteins in Viral Hepatitis.

Authors:  Zuliang Jie; Yuejin Liang; Panpan Yi; Hui Tang; Lynn Soong; Yingzi Cong; Kangling Zhang; Jiaren Sun
Journal:  J Immunol       Date:  2017-03-31       Impact factor: 5.422

Review 4.  Natural killer cells in liver diseases.

Authors:  Meijuan Zheng; Haoyu Sun; Zhigang Tian
Journal:  Front Med       Date:  2018-04-19       Impact factor: 4.592

5.  Monocyte-Derived CD11c+ Cells Acquire Plasmodium from Hepatocytes to Prime CD8 T Cell Immunity to Liver-Stage Malaria.

Authors:  Samarchith P Kurup; Scott M Anthony; Lisa S Hancox; Rahul Vijay; Lecia L Pewe; Steven J Moioffer; Ramakrishna Sompallae; Chris J Janse; Shahid M Khan; John T Harty
Journal:  Cell Host Microbe       Date:  2019-03-21       Impact factor: 21.023

6.  Liver-resident CD103+ dendritic cells prime antiviral CD8+ T cells in situ.

Authors:  Peter D Krueger; Taeg S Kim; Sun-Sang J Sung; Thomas J Braciale; Young S Hahn
Journal:  J Immunol       Date:  2015-02-23       Impact factor: 5.422

7.  Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B.

Authors:  Giovanni Sitia; Roberto Aiolfi; Pietro Di Lucia; Marta Mainetti; Amleto Fiocchi; Francesca Mingozzi; Antonio Esposito; Zaverio M Ruggeri; Francis V Chisari; Matteo Iannacone; Luca G Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-02       Impact factor: 11.205

8.  Characterization of the liver-draining lymph nodes in mice and their role in mounting regional immunity to HBV.

Authors:  Meijuan Zheng; Jiali Yu; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2013-01-07       Impact factor: 11.530

9.  Perihepatic nodes detected by point-of-care ultrasound in acute hepatitis and acute-on-chronic liver disease.

Authors:  I Che Feng; Szu Jen Wang; Ming Jen Sheu; Lok-Beng Koay; Ching Yih Lin; Chung Han Ho; Chi Shu Sun; Hsing Tao Kuo
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

10.  Bidirectional transendothelial migration of monocytes across hepatic sinusoidal endothelium shapes monocyte differentiation and regulates the balance between immunity and tolerance in liver.

Authors:  Henning W Zimmermann; Tony Bruns; Chris J Weston; Stuart M Curbishley; Evaggelia Liaskou; Ka-Kit Li; Yazid J Resheq; Paul W Badenhorst; David H Adams
Journal:  Hepatology       Date:  2015-11-23       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.